https://www.avient.com/resource-center?document_type=59&page=28
In-Vitro Diagnostic (IVD) Device
MEVOPUR™ Laser-Transmitting and Laser-Absorbing Pre-color Solution improved productivity and quality for healthcare device
https://www.avient.com/sites/default/files/resources/Innovation_Day_-_May_2014_0.pdf
Patterson
12:00-1:00 PM Lunch
PolyOne Corporation Page 7
PolyOne Commodity to Specialty
Transformation
• Volume driven,
commodity
producer
• Heavily tied to
cyclical end
markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2014
2015 and
beyond
• Steve Newlin
appointed,
Chairman,
President and CEO
• New leadership
team appointed
• Implementation of
four pillar strategy
• Focus on value
based selling,
investment in
commercial
resources and
innovation to drive
transformation
• 18 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster
growing, high
margin, less cyclical
end markets
• Key acquisitions
propel current and
future growth, as
well as margin
expansion
• Established
aggressive 2015
targets
• Continue specialty
transformation
• Targeting $2.50
adjusted EPS by
2015, nearly double
2013 EPS
• Drive double digit
operating income
and adjusted EPS
growth
PolyOne Corporation Page 8
Specialty
54%
PP&S
Distribution
28%
2013 Revenues: $3.8 Billion 2013 Revenues: $3.8 Billion
United
States
67%
Latin
America
$13
$31
$46 $46
$92 $96
$122
$195
$0
$50
$100
$150
$200
2006 2007 2008 2009 2010 2011 2012 2013
End Markets Specialty Operating Income
PolyOne At a Glance
Building &
9%
HealthCare
11% Appliance
Electronics &
Electrical
PolyOne Corporation Page 9
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34%
43%
62% 64%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 Q1 2014 2015
%
o
f
O
p
e
ra
ti
n
g
I
n
c
o
m
e
*
JV's Performance Products & Solutions Distribution Specialty
65-75%
Specialty OI $5M $46M $87M $195M $60M Target
Mix Shift Highlights Specialty Transformation
2015
Target
PolyOne Corporation Page 10
Confirmation of Our Strategy
The World’s Premier Provider of Specialized
Polymer Materials, Services and Solutions
Specialization Globalization
Operational
Excellence
Commercial
Excellence
PolyOne Corporation Page 11
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
450.00%
550.00%
PolyOne S&P 500
Strategy and Execution Drive Results
$0.12
$0.27
$0.21
$0.13
$0.68
$0.82
$1.00
$1.31
'06 '07 '08 '09 '10 '11 '12 '13
‘06-‘13 EPS CAGR = 41%
EPS Share Price vs.
Patterson
President and Chief Executive Officer
PolyOne Corporation Page 27
Well Positioned for Revenue Growth
Addressable Market by Platform
$540
$215
$120
$40
$260
$525
($ millions)
Design/Service
Sustainable
Solutions
Surface
Modification
Lightweighting
Thermal
Control
Flame
Retardancy
$1.0 - $2.0 Billion of revenue
generated from new
products in 5 years
Gross margin on new products
exceed current gross margin by at
least 10 percentage points
World class vitality index of ≥ 35%
2018
PolyOne Corporation Page 28
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 29
2006 2013
Revenue
($ millions)
Health and Wellness Evolution
General
purpose
tubing
TPE applications
from GLS
Specialty tubing
Ergonomic
enhancements
Pre-certified
biocompatible
colorants
Highly
sophisticated
catheter and
drug delivery
components
Chemical and
heat
sterilizable
materials
Authentication
and protection
technologies
Addressing
wellness,
prevention,
diagnostic and
therapy changes in
healthcare setting
Healthcare
packaging
solutions
2006
2015 &
Beyond
$416
$105
PolyOne Corporation Page 30
Transportation Evolution
General
purpose
formulations
(bumpers, roof
racks)
Long fiber for
lightweighting
Thermal
management for
LED lighting
Thermoset
composite
pultrusions
Conductive
polymers for EMI
shielding
Formulations for
aerospace interiors
Thermoplastic
composites
High temperature
formulations for
aerospace
Expand 3D printing
capabilities
2006
2015 &
Beyond
2006 2013
Revenue
($ millions)
$709
$315
PolyOne Corporation Page 31
Packaging Evolution
Masterbatch
colors and PVC
packaging
materials
TPEs to enhance
brand appeal and
consumer
functionality
Liquid color and
additive
technologies to
extend shelf life,
preserve taste and
differentiate brands
Leveraging color,
additives and sheet
technology for
healthcare and
consumer packaging
solutions
2006
2015 &
Beyond
2006 2013
Revenue
($ millions)
$612
$260
PolyOne Corporation Page 32
Consumer Evolution
Commodity plastic
and masterbatch
color solutions
Engineered
materials to
enhance customer
appeal through
visual and
performance
improvements
Formulated metal-
to-polymer
conversion to
enhance
performance and
reduce
manufacturing
costs
Biopolymers &
composite materials
leveraging unique
color technology to
build brand identity
2006
2015 &
Beyond
2006 2013
Revenue
($ millions)
$394
$228
PolyOne Corporation Page 33
Interactive Display
Introduction
PolyOne Corporation Page 34
Interactive Displays
INNOVATION DISCUSSION LEADER TECHNOLOGIES MARKETS
Polycast™ Bullet Resistant Sheet Aerospace
GlasArmor™ Ballistic Resistant Panels Security
reFlex™ Bio-Based Plasticizer Solutions
Wilflex™ Oasis Hydrate
InVisiO℠
Color Inspiration Forecast
In-Store Audits
OnColor™ Portfolio
Light Weighting
Thermal Management
Corrosion Resistance
Design Flexibility
Sustainability
Global Supply Chain
Ergonomics and Aesthetics
Consumer Appeal
9) Consumer Electronics Solutions
Walter Ripple
General Manager
GLS
Personal Electronics
Wearable Electronics
Hand Held Devices
Portable Audio
7) Metal Replacement Technology
Kurt Schuering
Vice President
Global Key Account Management
Aerospace
Sporting and Shooting
8) Medical Device Solutions
Dr.
Patricia Hubbard
Director
Global Technology
NEU™ View
Medical Devices &
Catheters
5) Sustainable Solutions
Michael A.
https://www.avient.com/sites/default/files/2023-10/308659_en_46154.pdf
Ltd.
30, Hsing Pang Road
33068 Taoyuan Taiwan
Scope
Design and manufacture of colour and additive
concentrates and specialty compounds for the
Healthcare and Medical device market.
Normative base
EN ISO 13485:2016 Medical devices –
Quality Management System
Reg. no. 46154 Validity 12.01.2022 – 11.01.2025
Issue 12.01.2022
Swiss Made
Swiss Association for Quality
and Management Systems (SQS)
Bernstrasse 103, 3052 Zollikofen, Switzerland
F.
https://www.avient.com/sites/default/files/2023-06/AVIENT_TPEs and LSR eBook.pdf
http://store.elsevier.com/Handbook-of-Polymer-Applications-in-Medicine-and-Medical-Devices/isbn-9780323221696/
UV Resistance
DID YOU KNOW?
Values reported as “typical” or stated without
a range do not state minimum or maximum properties; consult your sales representative for property ranges
and min/max specifications.
Processing conditions can cause material properties to shift from the values
stated in the information.
https://www.avient.com/sites/default/files/2025-02/case study snapshot-Ostomy bag-G2705.pdf
PowerPoint Presentation
MEDICAL DEVICE
MANUFACTURER
O S T O M Y B A G S E A L S
• Comply with ISO 10993 and FDA Class II medical device
regulations
• Offer Good sealing performance
• Provide technical supports for processing
recommendations
• Deliver a high compression set materials to improve
comfort
• Provided a medical-grade TPE to help the
customer meet necessary regulatory
specifications and gain market share
• Provided technical support during design
and the manufacturing process for EVA
bonding
• Delivered soft-touch feel and excellent
sealing performance
Versaflex HC Thermoplastic Elastomers -
G2705 Formulation
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/products/thermoplastic-elastomers/versaflex-hc-thermoplastic-elastomers
Slide 1: MEDICAL Device manufacturer
https://www.avient.com/sites/default/files/2021-10/information-systems-use-policy-final-9.1.2021.pdf
EXPECTATIONS FOR USE OF INFORMATION SYSTEMS
Users shall:
• Use all Information Systems consistent with their intended purpose, Avient business
objectives, and the Code of Conduct;
• Take necessary steps to prevent unauthorized access to and maintain security of
Confidential Data;
• Use only approved and secured methods when sharing Confidential Data and ensure
recipients have authorization to receive Confidential Data and/or have obtained prior
approval from User’s manager; and
• Obtain approval from Avient’s Information Technology department before procuring,
installing, connecting, using, or decommissioning software, systems, applications, or non-
Avient devices to or from Information Systems, including, but not limited to, on premise
and cloud-based systems.
Confidential 4 Avient IT Department
Information Systems Use Policy September 1, 2021
Additionally, the following Information Systems uses are prohibited unless specifically
authorized by Avient or authorized Avient IT representatives:
• Revealing account usernames, passwords, or other Personal Data to others or allowing use
of Information Systems by others, including family and other household members;
• Conducting any form of network monitoring that could intercept data not intended for the
recipient User;
• Circumventing User authentication or security of any Information Systems; or
• Using personal devices to access Confidential Data or connect to Information Systems.
Examples
of Information Systems include, but are not limited to, computer equipment (PCs, printers, copiers,
monitors), storage media (USB-devices, data disks/cards, cloud storage/applications), cell and desk phones,
internet access, internet servers, and operating systems.
https://www.avient.com/sites/default/files/2025-01/Stethoscope Dispersions Case Study Snapshot.pdf
MEDICAL DEVICE
MANUFACTURER
S T E T H O S C O P E S
• Provide a silicone paste colorant dispersion for liquid silicone
rubber (LSR) to use in stethoscope ear tips
• Create a custom-colored vinyl plastisol formulation for
stethoscope tubing
• Harmonize color across materials to meet specific process
and performance requirements
• Deliver effective communication and cross-functional
collaboration
• Offered dependable silicone paste colorants
that allowed for comfort and easy sterilization
• Provided a colored vinyl plastisol to reduce
tackiness and support product longevity
• Collaborated internally to align all materials and
provide color consistency across components
• Supported fast color changes and met quality
specifications through constant communication
and technical expertise
Silcopas Silicone Paste Colorants and
CORE Vinyl Plastisols for Healthcare
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/products/vinyl-formulations/vinyl-plastisols-organosols/core-vinyl-plastisols-healthcare
https://www.avient.com/products/polymer-colorants/colorant-dispersions/colorants-liquid-silicone-rubber
Slide 1: Medical device manufacturer
https://www.avient.com/products-1
They make possible our modes of transportation, healthcare devices, food availability, and electronics that power the world.
https://www.avient.com/investor-center/investor-news/archives?page=10
CLEVELAND, Sept. 13, 2021 /PRNewswire/ -- 5G technology will provide the backbone for a step-change in performance of mobile devices, allowing ultra
https://www.avient.com/news/archives?page=12
Avient unveils new grades of Cesa™ Withstand™ to include antimicrobial and antifungal additives for TPU film-laminated products and devices in app